Dr. Ann V. Gecevis is a Orland Park, Illinois based psychologist who is specialized in Clinical Psychology. Her current practice location is 1500 Ravinia Pl, Orland Park. Patients can reach her at 708-363-4111. Dr. Ann V. Gecevis is PHD in Clinical Psychology and her NPI number (Unique professional ID assigned by NPPES) is 1861647752. Dr. Ann V. Gecevis is a mental health professional with highly specialized training in the diagnosis and psychological treatment of mental, behavioral and emotional illnesses, including obsessive-compulsive disorder (OCD). Her main focus is on diagnosing and treating mental, emotional, and behavioral disorders. Some of the common disorders that she can treat are learning disabilities, substance abuse, depression, anxiety, and eating disorders.
Complete Profile:
Dr. Ann V. Gecevis speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Ann V. Gecevis
Specialization:
Clinical Psychology
Gender:
Female
Credentials:
PHD
Practice Address:
1500 Ravinia Pl, Orland Park, Illinois, 60462-3962
Phone:
708-363-4111
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1861647752
NPI Enumeration Date:
19 Nov, 2008
NPI Last Update On:
19 Nov, 2008
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Ann V. Gecevis 1500 Ravinia Pl, Orland Park, Illinois
Zip:
60462-3962
Phone Number:
708-363-4111
Patients can reach Dr. Ann V. Gecevis at 1500 Ravinia Pl, Orland Park, Illinois or can call to book an appointment on 708-363-4111.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.